{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:43:29Z","timestamp":1794930209036,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To comprehensively evaluate the influence of dienogest (DNG) versus non-DNG pretreatment on in vitro fertilization and embryo transfer (IVF-ET) outcomes for patients with endometriosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Embase, Cochrane Library, Web of Science, CNKI, WanFang, and VIP were comprehensively searched for relevant publications until September 14, 2022. Primary outcomes included clinical pregnancy rate and live birth rate. Secondary outcomes included retrieved oocytes, mature oocytes, blastocysts, growing follicles, transferrable embryos, fertilization rate, implantation rate, and miscarriage rate. Subgroup analysis was performed according to different grouping methods and embryo types.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five studies of 568 females with endometriosis were involved in this systematic review and meta-analysis. DNG treatment exhibited similar effects to non-DNG treatment on either the primary or the secondary outcomes (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The DNG group had a significantly greater clinical pregnancy rate than the non-hormonal treatment group (pooled relative risk [RR]: 2.055, 95% confidence interval [CI]: 1.275, 3.312, <jats:italic>P<\/jats:italic>\u2009=\u20090.003), and exhibited a significantly lower clinical pregnancy rate than the long gonadotropin-releasing hormone agonist (GnRH-a) group (RR: 0.542, 95%CI: 0.321, 0.916, <jats:italic>P<\/jats:italic>\u2009=\u20090.022). For patients undergoing fresh embryo transfer, the DNG group displayed a significantly greater clinical pregnancy rate versus the non-DNG group (pooled RR: 1.848, 95%CI: 1.234, 2.767, <jats:italic>P<\/jats:italic>\u2009=\u20090.003). Patients receiving DNG had a significantly greater live birth rate than those with non-hormonal treatment (pooled RR: 2.136, 95%CI: 1.223, 3.734, <jats:italic>P<\/jats:italic>\u2009=\u20090.008), while having a significantly lower live birth rate than the long GnRH-a group (RR: 0.441, 95%CI: 0.214, 0.907, <jats:italic>P<\/jats:italic>\u2009=\u20090.026). While using fresh embryos, patients with DNG treatment had an increased live birth rate, compared with those without DNG treatment (pooled RR: 2.132, 95%CI: 1.090, 4.169, <jats:italic>P<\/jats:italic>\u2009=\u20090.027).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>DNG treatment may have similar effects to non-DNG treatment on IVF-ET outcomes. The clinical pregnancy rate and live birth rate after DNG treatment may be significantly higher than those after non-hormonal treatment. More evidence is warranted to corroborate these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01245-8","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:01:35Z","timestamp":1692176495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Wenjing","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261\u201375.","journal-title":"Nat Rev Endocrinol"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","volume":"362","author":"LC Giudice","year":"2010","unstructured":"Giudice LC. Clinical practice. Endometriosis N Engl J Med. 2010;362:2389\u201398.","journal-title":"Endometriosis N Engl J Med"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a114634","volume":"125","author":"DE Houston","year":"1987","unstructured":"Houston DE, Noller KL, Melton LJ 3rd, Selwyn BJ, Hardy RJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970\u20131979. Am J Epidemiol. 1987;125:959\u201369.","journal-title":"Am J Epidemiol"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bpobgyn.2018.01.019","volume":"51","author":"F Prefumo","year":"2018","unstructured":"Prefumo F, Rossi AC. Endometriosis, endometrioma, and ART results: Current understanding and recommended practices. Best Pract Res Clin Obstet Gynaecol. 2018;51:34\u201340.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1245_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/S0015-0282(02)03112-6","volume":"77","author":"K Barnhart","year":"2002","unstructured":"Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77:1148\u201355.","journal-title":"Fertil Steril"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/humupd\/8.1.79","volume":"8","author":"A Bergqvist","year":"2002","unstructured":"Bergqvist A, D\u2019Hooghe T. Mini symposium on pathogenesis of endometriosis and treatment of endometriosis-associated subfertility. Introduction: the endometriosis enigma. Hum Reprod Update. 2002;8:79\u201383.","journal-title":"Hum Reprod Update"},{"key":"1245_CR7","first-page":"Cd004635","volume":"2006","author":"HN Sallam","year":"2006","unstructured":"Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006;2006:Cd004635.","journal-title":"Cochrane Database Syst Rev"},{"key":"1245_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13048-014-0100-8","volume":"7","author":"H Tamura","year":"2014","unstructured":"Tamura H, Takasaki A, Nakamura Y, Numa F, Sugino N. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. J Ovarian Res. 2014;7:100.","journal-title":"J Ovarian Res"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000331642","volume":"72","author":"OM Fischer","year":"2011","unstructured":"Fischer OM, Kaufmann-Reiche U, Moeller C, Fuhrmann U. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration. Gynecol Obstet Invest. 2011;72:145\u201351.","journal-title":"Gynecol Obstet Invest"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.fertnstert.2007.03.042","volume":"89","author":"L Fu","year":"2008","unstructured":"Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T, et al. Dienogest inhibits BrdU uptake with G0\/G1 arrest in cultured endometriotic stromal cells. Fertil Steril. 2008;89:1344\u20137.","journal-title":"Fertil Steril"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/09513590.2017.1415676","volume":"33","author":"V Muller","year":"2017","unstructured":"Muller V, Kogan I, Yarmolinskaya M, Niauri D, Gzgzyan A, Aylamazyan E. Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF. Gynecol Endocrinol. 2017;33:18\u201321.","journal-title":"Gynecol Endocrinol"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13048-019-0597-y","volume":"12","author":"H Tamura","year":"2019","unstructured":"Tamura H, Yoshida H, Kikuchi H, Josaki M, Mihara Y, Shirafuta Y, et al. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res. 2019;12:123.","journal-title":"J Ovarian Res"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.rbmo.2020.07.022","volume":"41","author":"F Barra","year":"2020","unstructured":"Barra F, Lagan\u00e0 AS, Scala C, Garzon S, Ghezzi F, Ferrero S. Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reprod Biomed Online. 2020;41:859\u201368.","journal-title":"Reprod Biomed Online"},{"key":"1245_CR16","doi-asserted-by":"publisher","first-page":"100470","DOI":"10.1016\/j.repbio.2020.100470","volume":"21","author":"N Iwami","year":"2021","unstructured":"Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Mizuuchi M, et al. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone. Reprod Biol. 2021;21:100470.","journal-title":"Reprod Biol"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12884-021-03736-2","volume":"21","author":"E Khalifa","year":"2021","unstructured":"Khalifa E, Mohammad H, Abdullah A, Abdel-Rasheed M, Khairy M, Hosni M. Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial. BMC Pregnancy Childbirth. 2021;21:264.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1245_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/17425255.2018.1461840","volume":"14","author":"F Barra","year":"2018","unstructured":"Barra F, Scala C, Ferrero S. Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. Expert Opin Drug Metab Toxicol. 2018;14:399\u2013415.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1245_CR19","doi-asserted-by":"crossref","unstructured":"Barra F, Scala C, Leone Roberti Maggiore U, Ferrero S. Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis. Journal of clinical medicine. 2020; 9.","DOI":"10.3390\/jcm9010154"},{"key":"1245_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1517\/14656566.2014.943734","volume":"15","author":"N Bizzarri","year":"2014","unstructured":"Bizzarri N, Remorgida V, Leone Roberti Maggiore U, Scala C, Tafi E, Ghirardi V, et al. Dienogest in the treatment of endometriosis. Expert Opin Pharmacother. 2014;15:1889\u2013902.","journal-title":"Expert Opin Pharmacother"},{"key":"1245_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejogrb.2014.10.036","volume":"183","author":"M Morotti","year":"2014","unstructured":"Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur J Obstet Gynecol Reprod Biol. 2014;183:188\u201392.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1245_CR22","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1095\/biolreprod57.3.580","volume":"57","author":"M Manikkam","year":"1997","unstructured":"Manikkam M, Rajamahendran R. Progesterone-induced atresia of the proestrous dominant follicle in the bovine ovary: changes in diameter, insulin-like growth factor system, aromatase activity, steroid hormones, and apoptotic index. Biol Reprod. 1997;57:580\u20137.","journal-title":"Biol Reprod"},{"key":"1245_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2527\/1998.763850x","volume":"76","author":"CM McDowell","year":"1998","unstructured":"McDowell CM, Anderson LH, Kinder JE, Day ML. Duration of treatment with progesterone and regression of persistent ovarian follicles in cattle. J Anim Sci. 1998;76:850\u20135.","journal-title":"J Anim Sci"},{"key":"1245_CR24","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1177\/0091270011423664","volume":"52","author":"C Klipping","year":"2012","unstructured":"Klipping C, Duijkers I, Remmers A, Faustmann T, Zurth C, Klein S, et al. Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women. J Clin Pharmacol. 2012;52:1704\u201313.","journal-title":"J Clin Pharmacol"},{"key":"1245_CR25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/BF03345616","volume":"31","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa S, Shimizu Y, Nagaoka T, Tokado H, Imada K, Mizuguchi K. Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys. J Endocrinol Invest. 2008;31:636\u201341.","journal-title":"J Endocrinol Invest"},{"key":"1245_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.maturitas.2012.01.018","volume":"71","author":"X Ruan","year":"2012","unstructured":"Ruan X, Seeger H, Mueck AO. The pharmacology of dienogest. Maturitas. 2012;71:337\u201344.","journal-title":"Maturitas"},{"key":"1245_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00003495-199856050-00007","volume":"56","author":"RH Foster","year":"1998","unstructured":"Foster RH, Wilde MI. Dienogest. Drugs. 1998;56:825\u201333 discussion 34\u20135.","journal-title":"Drugs"},{"key":"1245_CR28","doi-asserted-by":"crossref","unstructured":"Klipping C, Duijkers I, Faustmann TA, Klein SF, Schuett BJF, Sterility. Pharmacodynamic study of four oral dosages of dienogest. 2010; 94: S181-S.","DOI":"10.1016\/j.fertnstert.2010.07.708"},{"key":"1245_CR29","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2165\/11206320-000000000-00000","volume":"70","author":"PL McCormack","year":"2010","unstructured":"McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs. 2010;70:2073\u201388.","journal-title":"Drugs"},{"key":"1245_CR30","first-page":"133","volume":"42","author":"M Oettel","year":"2020","unstructured":"Oettel M, Zentel HJ, Nickisch K. A progestin isn\u2019t a progestin: dienogest for endometriosis as a blueprint for future research - Review as a contribution for discussion. Horm Mol Biol Clin Invest. 2020;42:133\u201342.","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1245_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.fertnstert.2011.11.005","volume":"97","author":"K Yamanaka","year":"2012","unstructured":"Yamanaka K, Xu B, Suganuma I, Kusuki I, Mita S, Shimizu Y, et al. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture. Fertil Steril. 2012;97:477\u201382.","journal-title":"Fertil Steril"},{"key":"1245_CR32","doi-asserted-by":"crossref","unstructured":"Grandi G, Mueller M, Bersinger N, Papadia A, Nirgianakis K, Cagnacci A, et al. Progestin suppressed inflammation and cell viability of tumor necrosis factor-\u03b1-stimulated endometriotic stromal cells. American journal of reproductive immunology (New York, NY : 1989). 2016; 76: 292\u20138.","DOI":"10.1111\/aji.12552"},{"key":"1245_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejogrb.2014.03.019","volume":"177","author":"N Maeda","year":"2014","unstructured":"Maeda N, Izumiya C, Taniguchi K, Matsushima S, Mita S, Shimizu Y, et al. Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-\u03b1 production in peritoneal fluid cells from women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;177:48\u201351.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1245_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1757-2215-5-31","volume":"5","author":"A Hayashi","year":"2012","unstructured":"Hayashi A, Tanabe A, Kawabe S, Hayashi M, Yuguchi H, Yamashita Y, et al. Dienogest increases the progesterone receptor isoform B\/A ratio in patients with ovarian endometriosis. J OvarianRes. 2012;5:31.","journal-title":"J OvarianRes"},{"key":"1245_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/00016348709022068","volume":"66","author":"J Lyndrup","year":"1987","unstructured":"Lyndrup J, Thorpe S, Glenth\u00f8j A, Obel E, Sele V. Altered progesterone\/estrogen receptor ratios in endometriosis. A comparative study of steroid receptors and morphology in endometriosis and endometrium. Acta Obstet Gynecol Scand. 1987;66:625\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1245_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/09513590.2016.1232550","volume":"32","author":"V Muller","year":"2016","unstructured":"Muller V, Makhmadalieva M, Kogan I, Fedorova I, Lesik E, Komarova E, et al. Ectopic pregnancy following in vitro fertilization: meta-analysis and single-center experience during 6 years. Gynecolo Endocrinol. 2016;32:69\u201374.","journal-title":"Gynecolo Endocrinol"},{"key":"1245_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","volume":"91","author":"T Harada","year":"2009","unstructured":"Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2013a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 2009;91:675\u201381.","journal-title":"Fertil Steril"},{"key":"1245_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/humrep\/dep469","volume":"25","author":"T Strowitzki","year":"2010","unstructured":"Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633\u201341.","journal-title":"Hum Reprod"},{"key":"1245_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","volume":"73","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids. 2008;73:222\u201331.","journal-title":"Steroids"},{"key":"1245_CR40","first-page":"Cd008475","volume":"2010","author":"J Brown","year":"2010","unstructured":"Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010;2010:Cd008475.","journal-title":"Cochrane Database Syst Rev"},{"key":"1245_CR41","first-page":"S260","volume":"90","author":"Treatment of pelvic pain associated with endometriosis","year":"2008","unstructured":"Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90:S260\u20139.","journal-title":"Fertil Steril"},{"key":"1245_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003495-200969060-00002","volume":"69","author":"P Vercellini","year":"2009","unstructured":"Vercellini P, Somigliana E, Vigan\u00f2 P, Abbiati A, Barbara G, Crosignani PG. Endometriosis: current therapies and new pharmacological developments. Drugs. 2009;69:649\u201375.","journal-title":"Drugs"},{"key":"1245_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.rbmo.2016.07.010","volume":"33","author":"S D'Arpe","year":"2016","unstructured":"D\u2019Arpe S, Di Feliciantonio M, Candelieri M, Franceschetti S, Piccioni MG, Bastianelli C. Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review. Reprod Biomed Online. 2016;33:436\u201348.","journal-title":"Reprod Biomed Online"},{"key":"1245_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","volume":"298","author":"N Iwami","year":"2018","unstructured":"Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Moriwaka O, et al. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology. Arch Gynecol Obstet. 2018;298:663\u201371.","journal-title":"Arch Gynecol Obstet"},{"key":"1245_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humrep\/dex367","volume":"33","author":"S Yu","year":"2018","unstructured":"Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, et al. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles. Hum Reprod. 2018;33:229\u201337.","journal-title":"Hum Reprod"},{"key":"1245_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/IJWH.S77202","volume":"7","author":"T Strowitzki","year":"2015","unstructured":"Strowitzki T, Faustmann T, Gerlinger C, Schumacher U, Ahlers C, Seitz C. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Women\u2019s Health. 2015;7:393\u2013401.","journal-title":"Int J Women's Health"},{"key":"1245_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2217\/WHE.09.72","volume":"6","author":"T Harada","year":"2010","unstructured":"Harada T, Taniguchi F. Dienogest: a new therapeutic agent for the treatment of endometriosis. Womens Health (Lond). 2010;6:27\u201335.","journal-title":"Womens Health (Lond)"},{"key":"1245_CR48","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.fertnstert.2004.11.042","volume":"83","author":"S Horie","year":"2005","unstructured":"Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril. 2005;83:1530\u20135.","journal-title":"Fertil Steril"},{"key":"1245_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.fertnstert.2016.12.024","volume":"107","author":"MA Bedaiwy","year":"2017","unstructured":"Bedaiwy MA, Allaire C, Alfaraj S. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril. 2017;107:537\u201348.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01245-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T20:22:36Z","timestamp":1700425356000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01245-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01245-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}